These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 10037188

  • 1. In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector.
    Rogers BE, McLean SF, Kirkman RL, Della Manna D, Bright SJ, Olsen CC, Myracle AD, Mayo MS, Curiel DT, Buchsbaum DJ.
    Clin Cancer Res; 1999 Feb; 5(2):383-93. PubMed ID: 10037188
    [Abstract] [Full Text] [Related]

  • 2. Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector.
    Rogers BE, Zinn KR, Lin CY, Chaudhuri TR, Buchsbaum DJ.
    Cancer; 2002 Feb 15; 94(4 Suppl):1298-305. PubMed ID: 11877760
    [Abstract] [Full Text] [Related]

  • 3. Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer.
    Rogers BE, Rosenfeld ME, Khazaeli MB, Mikheeva G, Stackhouse MA, Liu T, Curiel DT, Buchsbaum DJ.
    J Nucl Med; 1997 Aug 15; 38(8):1221-9. PubMed ID: 9255155
    [Abstract] [Full Text] [Related]

  • 4. Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector.
    Rogers BE, Curiel DT, Mayo MS, Laffoon KK, Bright SJ, Buchsbaum DJ.
    Cancer; 1997 Dec 15; 80(12 Suppl):2419-24. PubMed ID: 9406692
    [Abstract] [Full Text] [Related]

  • 5. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
    Hofland LJ, Lamberts SW, van Hagen PM, Reubi JC, Schaeffer J, Waaijers M, van Koetsveld PM, Srinivasan A, Krenning EP, Breeman WA.
    J Nucl Med; 2003 Aug 15; 44(8):1315-21. PubMed ID: 12902423
    [Abstract] [Full Text] [Related]

  • 6. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.
    Bakker WH, Albert R, Bruns C, Breeman WA, Hofland LJ, Marbach P, Pless J, Pralet D, Stolz B, Koper JW.
    Life Sci; 1991 Aug 15; 49(22):1583-91. PubMed ID: 1658515
    [Abstract] [Full Text] [Related]

  • 7. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
    Breeman WA, Hofland LJ, van der Pluijm M, van Koetsveld PM, de Jong M, Setyono-Han B, Bakker WH, Kwekkeboom DJ, Visser TJ, Lamberts SW.
    Eur J Nucl Med; 1994 Apr 15; 21(4):328-35. PubMed ID: 7911760
    [Abstract] [Full Text] [Related]

  • 8. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
    Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R.
    Curr Pharm Des; 2002 Apr 15; 8(20):1781-807. PubMed ID: 12171531
    [Abstract] [Full Text] [Related]

  • 9. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
    Ferone D, van Hagen MP, Kwekkeboom DJ, van Koetsveld PM, Mooy DM, Lichtenauer-Kaligis E, Schönbrunn A, Colao A, Lamberts SW, Hofland LJ.
    J Clin Endocrinol Metab; 2000 Apr 15; 85(4):1719-26. PubMed ID: 10770220
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D, Béhé M, Walter MA, Chen J, Powell P, Mikolajczak R, Mäcke HR.
    J Nucl Med; 2005 Sep 15; 46(9):1561-9. PubMed ID: 16157541
    [Abstract] [Full Text] [Related]

  • 14. The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas.
    Colao A, Lastoria S, Ferone D, Varrella P, Marzullo P, Pivonello R, Cerbone G, Acampa W, Salvatore M, Lombardi G.
    J Endocrinol Invest; 1999 Mar 15; 22(3):176-83. PubMed ID: 10219884
    [Abstract] [Full Text] [Related]

  • 15. Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re.
    Zinn KR, Buchsbaum DJ, Chaudhuri TR, Mountz JM, Grizzle WE, Rogers BE.
    J Nucl Med; 2000 May 15; 41(5):887-95. PubMed ID: 10809205
    [Abstract] [Full Text] [Related]

  • 16. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
    Bangard M, Béhé M, Guhlke S, Otte R, Bender H, Maecke HR, Biersack HJ.
    Eur J Nucl Med; 2000 Jun 15; 27(6):628-37. PubMed ID: 10901448
    [Abstract] [Full Text] [Related]

  • 17. In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complex.
    Lukinius A, Ohrvall U, Westlin JE, Oberg K, Tiensuu Janson E.
    Acta Oncol; 1999 Jun 15; 38(3):383-7. PubMed ID: 10380832
    [Abstract] [Full Text] [Related]

  • 18. Generally applicable, convenient solid-phase synthesis and receptor affinities of octreotide analogs.
    Edwards WB, Fields CG, Anderson CJ, Pajeau TS, Welch MJ, Fields GB.
    J Med Chem; 1994 Oct 28; 37(22):3749-57. PubMed ID: 7966134
    [Abstract] [Full Text] [Related]

  • 19. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A, Krenning E, Bernard B, Reubi JC, Breeman W, de Jong M.
    Eur J Nucl Med Mol Imaging; 2005 Nov 28; 32(11):1288-95. PubMed ID: 16021448
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.